Search results
3 days ago · Lilly in April said Zepbound, known chemically as tirzepatide, helped reduce episodes of irregular breathing in patients with obstructive sleep apnea by 55% in the first study and by 62.8% in the ...
4 days ago · Eli Lilly on Friday reiterated that Zepbound met the main goal of the trial, which was reducing AHI events. Zepbound led to an average of 27.4 fewer AHI events per hour at 52 weeks in people who ...
3 days ago · The weight loss drug tirzepatide, the medication in Zepbound and Mounjaro, may help treat severe sleep apnea, a new study finds. Drugmaker Eli Lilly and Co., who paid for the research, has asked ...
1 day ago · Taking a deeper look at the results, Zepbound charted a mean reduction of up to 62.8% on the apnea-hypopnea index (AHI), which measures OSA severity by tracking sleep-related breathing issues per ...
5 days ago · Zepbound (tirzepatide) and Ozempic (semaglutide) are both once-weekly injections. Zepbound is approved for weight loss, while Ozempic is approved for Type 2 diabetes. Ozempic can also lower the risk of serious cardiovascular problems in certain people.
4 days ago · New research showed that tirzepatide, the compound in Zepbound, improved symptoms of obstructive sleep apnea. By Dani Blum Reporting from the American Diabetes Association conference in Orlando ...
5 days ago · Zepbound ® is an injectable prescription medicine that, used along with a reduced-calorie diet and increased physical activity, may help adults with obesity, or with excess weight (overweight) who also have weight-related medical problems, lose weight and keep it off.
